Mirikizumab Shows Promise for Moderate to Severe Crohn’s
WASHINGTON, DC — The selective interleukin (IL)–23p29 monoclonal antibody mirikizumab demonstrated safety and efficacy in people with moderate to severe ...
Read more
Tag: Mirikizumab
The Earth News is an independent English-language daily published Website from all around the World News